Last reviewed · How we verify
NCT03630107
In-Use Test of a Cosmetic Product in Subjects With Chronically Itchy Scalp
NA trial testing WO 5101 Shampoo for Scalp and Hair in Pruritus of the Scalp in 34 participants. Completed in 15 March 2018.
15 March 2018
Quick facts
| Lead sponsor | Dr. August Wolff GmbH & Co. KG Arzneimittel |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 34 |
| Start date | 15 February 2018 |
| Primary completion | 15 March 2018 |
| Estimated completion | 15 March 2018 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- WO 5101 Shampoo for Scalp and Hair
Conditions studied
- Pruritus of the Scalp — all drugs for Pruritus of the Scalp →
Sponsor
Dr. August Wolff GmbH & Co. KG Arzneimittel
Who can join
Adults 18 to 99, any sex, with Pruritus of the Scalp. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to evaluate the tolerance of the Shampoo (WO 5101) on the scalp by a dermatologist and by the subjects themselves after four weeks of regular product use. Additional objective of this clinical in-use study was to evaluate the cosmetic features and the acceptance of the product by means of a questionnaire at the end of the 4-week treatment period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03630107
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Dr. August Wolff GmbH & Co. KG Arzneimittel trials
Trials by the same sponsor.
- NCT06244615 — Clinical Trial of a Mouth and Throat Rinse for the Treatment of Acute Sore Throat · NA · completed
- NCT05863104 — Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyper · Phase 2 · completed
- NCT05211505 — Investigation of Efficacy and Tolerability of WO 2707, a MoistCream Cremolum, in Postmenopausal Women Suffering From Sym · Phase 4 · completed
- NCT04222647 — Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With · Phase 2 · completed
- NCT03658616 — Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03630107 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dr. August Wolff GmbH & Co. KG Arzneimittel
- Last refreshed: 19 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03630107.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing